2
Clinical Trials associated with EthoximodA Single-center, Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Ethoximod in Healthy Subjects.
The goal of this clinical trial is to evaluate the tolerability, pharmacokinetics and pharmacodynamics of Ethoximod in healthy subjects. The main questions it arms to answer are:
1. to evaluate the safety and tolerance of Ethoximod in healthy subjects after single or repeated doses.
2. to assess the pharmacokinetics and pharmacodynamics of Ethoximod in healthy subjects after single or repeated doses.
3. to evaluate of the effect of food on the pharmacokinetics of Ethoximod in healthy subjects Participants will receive test tablets or placebo at the indicated date and collect blood samples.
艾托莫德片在健康受试者中单次给药的安全性、耐受性及药代动力学/药效动力学研究
[Translation] Safety, tolerability and pharmacokinetic/pharmacodynamic study of a single dose of izolimod tablets in healthy subjects
评价中国健康成年男性和女性受试者单次口服艾托莫德片后的安全性和耐受性; 研究中国健康成年男性和女性受试者单次口服艾托莫德片后的药代动力学和药效动力学特征。
[Translation] To evaluate the safety and tolerability of Etomod tablets after a single oral dose in healthy male and female Chinese adult subjects; To study the pharmacokinetic and pharmacodynamic characteristics of Etomod tablets after a single oral dose in healthy male and female Chinese adult subjects.
100 Clinical Results associated with Ethoximod
100 Translational Medicine associated with Ethoximod
100 Patents (Medical) associated with Ethoximod
100 Deals associated with Ethoximod